Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
O2 RegenTech
company
About
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $600K
- Industries
- Clinical Trials,Commercial,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
O2 RegenTech LLC is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary, patented technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote and accelerate chronic wound healing.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$600K
O2 RegenTech has raised a total of
$600K
in funding over 2 rounds. Their latest funding was raised on
Jan 26, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 26, 2017 | Grant | $600K | 2 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
O2 RegenTech has made 1 investments. Their most recent investment was on
Jun 14, 2021, when Convosight raised $9M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 14, 2021
Convosight
|
Series A | $9M | SaaS | — |
Investors
Number of Lead Investors
Number of Investors
—
2
O2 RegenTech is funded by 2 investors.
National Institutes of Health
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
National Science Foundation
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
